Role of cytochrome P450 1A2 and N-acetyltransferase 2 in 2,6-dimethylaniline induced genotoxicity
DOI:
https://doi.org/10.1590/s2175-97902022e19221Keywords:
N-Acetyltransferase 2. 2,6-Dimethylaniline, Genotoxicity, Cytochrome P450 1A2Abstract
The purpose of the current work was to assess a possible role of cytochrome P450 1A2 (CYP1A2) and N-acetyltransferase 2 (NAT2) in the metabolic activation of 2,6-dimethylaniline (2,6-DMA) and also clarify the function of DNA repair in affecting the ultimate mutagenic potency. Two cell lines, nucleotide excision repair (NER)-deficient 5P3NAT2 and proficient 5P3NAT2R9 both expressing CYP1A2 and NAT2, were treated with 2,6-DMA for 48 h or its metabolites for 1 h. Cell survival determined by trypan blue exclusion and MTT assays, and 8-azaadenine-resistant mutants at the adenine phosphoribosyltransferase (aprt) gene locus were evaluated. 5P3NAT2 and 5P3NAT2R9 cells treated with 2,6-DMA and its metabolites showed a dose-dependent increase in cytotoxicity and mutant fraction; N-OH-2,6-DMA and 2,6-DMAP in serum-free α-minimal essential medium (MEM) are more potent than 2,6-DMA in complete MEM. 5P3NAT2 cells was more sensitive to the cytotoxic and mutagenic action than 5P3NAT2R9 cells. H2DCFH-DA assay showed dose-dependent ROS production under 2,6- DMAP treatment. These findings indicate that the genotoxic effects of 2,6-DMA are mediated by CYP1A2 activation via N-hydroxylation and the subsequent esterification by the phase II conjugation enzyme NAT2, and through the generation of ROS by hydroxylamine and/or aminophenol metabolites. NER status is also an important contributor.
Downloads
References
Beland FA, Melchior WB Jr, Mourato LLG, Santos MA, Marques MM. Arylamine-DNA adduct conformation in relation to mutagenesis. Mutat Res. 1997;367(1-2):13-9.
Chao MW, Kim MY, Ye W, Ge J, Trudel LJ, Belanger C et al. Genotoxicity of 2,6- and 3,5-Dimethylaniline in cultured mammalian cells: the role of reactive oxygen species. Toxicol Sci. 2012;130(1):48-59.
Chao MW, Erkekoglu P, Tseng CY, Ye W, Ge J, Trudel LJ, et al. Protective effects of ascorbic acid against the genetic and epigenetic alterations induced by 3,5-dimethylaminophenol in AA8 cells. J Appl Toxicol. 2014a;35(5):466-77.
Chao MW, Erkekoglu P, Tseng CY, Ye W, Ge J, Trudel LJ, et al. Intracellular generation of ROS by 3,5-dimethylaminophenol: persistence, cellular response, and impact of molecular toxicity. Toxicol Sci . 2014b;141(1):300-13.
Erkekoglu P, Chao MW, Ye W, Ge J, Trudel LJ, Skipper PL, et al. Cytoplasmic and nuclear toxicity of 3,5-dimethylaminophenol and potential protection by selenocompounds. Food Chem Toxicol. 2014;72:98-110.
Gan J, Skipper PL, Gago-Dominguez M, Arakawa K, Ross RK, Yu MC, et al. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst. 2004;96(19):1425-31.
Gan J, Skipper PL, Tannenbaum SR. Oxidation of 2,6-dimethylaniline by recombinant human cytochrome P450s and human liver microsomes. Chem Res Toxicol. 2001;14(6):672-7.
Hanna PE. Metabolic activation and detoxification of arylamines. Curr Med Chem. 1996;3(3):195-210.
Haseman JK, Halley JR. An update of the National Toxicology Program database on nasal carcinogens. Mutat Res . 1997;380(1-2):3-11.
Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res . 2002;506-507:65-77.
Jong PJ, Grosovsky AJ, Glickman BW. Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: An analysis at the DNA sequence level. Proc Natl Acad Sci USA. 1988;85(22):3499-503.
KKim MY. The role of nucleotide excision repair on 2,6- and 3,5-dimethylaniline-induced genotoxicity. J Environ Biol. 2020;41(2):216-221.
Marques MM, da Costa GG, Blankenship LR, Culp SJ, Beland FA. The effect of deuterium and fluorine substitution upon the mutagenicity of N-hydroxy-2,6-dimethylaniline. Mutat Res . 2002;506-550:41-8.
Meng Q, Grosovsky AJ, Shi X, Walker VE. Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3’-azido-3'-deoxythymidine. Mutagenesis. 2000;15(5):405-10.
Moon SH, Kim MY. Metabolic activation of 2,6-dimethylaniline:mutational specificity in the gpt gene of AS52 cells. Asian J Pharm Clin Res. 2018a;11(9):394-397.
Moon SH, Kim MY. Genotoxicity of N-hydrocy and aminophenol metabolites of 2,6-and 3,5-dimethylaniline at the hypoxanthineguanine phosphoribosyltransferase locus in TK6 cells. Asian J Pharm Clin Res . 2018b;11(9):398-401.
Nohmi T, Miyata R, Yoshikawa K, Nakadate M, Ishidate M Jr. Metabolic activation of 2,4-xylidine and its mutagenic metabolite. Biochem Pharmacol. 1983;32:735-8.
Skipper PL, Kim MY, Sun HLP, Wogan GN, Tannenbaum SR. Monocyclic aromatic amines as potential human carcinogens: old is new again. Carcinogenesis. 2010;31(1):50-8.
Skipper PL, Tannenbaum SR, Ross RK, Yu MC. Nonsmoking- related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12(1):503-7.
Skipper PL, Trudel LJ, Kensler TW, Groopman JD, Egner PA, Liberman RG, et al. DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice. Chem Res Toxicol . 2006;19(8):1086-90.
Snyderwine EG. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms. Cancer Lett. 1999;143(2):211-5.
Sodimbaku V, Pujari L. Urolithiasis-an updated review over genetics, pathophysiogy and its clinical management. Int J Pharm Pharm Sci. 2014;6(11):23-31.
Tao L, Day BW, Hu B, Xiang YB, Wang R, Stern MC, et al. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study. Cancer Epidemiol Biomarkers Prev . 2013;22(5):937-45.
Thompson LH, Fong F, Brookman KW. Validation of conditions for efficient detection of Hprt and Aprt mutation in suspension cultured Chinese hamster ovary cells. Mutat Res . 1980a;74:21-36.
Thompson LH, Rubin, JS, Cleaver JE, Whitmore GF, Brookman KW. A screening method for isolating DNA repair-deficient mutants of CHO cells. Somat Cell Mol Genet. 1980b;6:391- 405.
Thompson LH, Wu RW, Felton JS. Introduction of cytochrome P4501A2 metabolic capability into cell lines genetically matched for DNA repair proficiency/deficiency. Pro Natl Acad Sci USA. 1991;88:3827-31.
U. S. National Toxicology Program. Toxicology and carcinogenesis studies of 2,6-xylidine (2,6-dimethylaniline) (CAS No. 87-62-7) in Charles River CD rats (Feed Studies). Technical Report Series No. 278. Research Triangle Park, NC: National Toxicology Program; 1990.
Weber CA, Salazar EP, Stewart SA, Thompson LH. Molecular cloning and biological characterization of human gene, ERCC2, that corrects the nucleotide excision repair defect in CHO UV5 cells. Mol Cell Biol. 1988;8:1137-46.
Wu RW, Tucker JD, Sorensen KJ, Thompson LH, Felton JS. Differential effect of acetyltransferase expression on the genotoxicity of heterocyclic amines in CHO cells. Mutat Res . 1997;390:93-103.
Wu RW, Panteleakos FN, Felton JS. Development and characterization of CHO repair-proficient cell lines for comparative mutagenicity and metabolism of heterocyclic amines from cooked food. Environ Mol Mutagen. 2003;41(1):7-13.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
